Standardized definitions and clinical endpoints in trials investigating endovascular repair of aortic dissections.

Diehm, Nicolas; Vermassen, F; van Sambeek, M R H M (2013). Standardized definitions and clinical endpoints in trials investigating endovascular repair of aortic dissections. European journal of vascular and endovascular surgery EJVES, 46(6), pp. 645-650. Elsevier 10.1016/j.ejvs.2013.08.017

Text Standardized definitions and clinical endpoints.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (154kB)

OBJECTIVES

Endovascular therapy is a rapidly expanding option for the treatment of patients with aortic dissection (AD) and various studies have been published. These trials, however, are often difficult to interpret and compare because they do not utilize uniform clinical endpoint definitions.

METHODS

The DEFINE Group is a collaborative effort of an ad hoc multidisciplinary team from various specialties involved in AD therapy in Europe and the United States. DEFINE's goal was to arrive at a broad based consensus for baseline and endpoint definitions in trials for endovascular therapy of various vascular pathologies. In this project, which started in December 2006, the individual team members reviewed the existing pertinent literature. Following this, a series of telephone conferences and face-to-face meetings were held to agree upon definitions. Input was also obtained from regulatory (United States Food and Drug Administration) and industry (device manufacturers with an interest in peripheral endovascular revascularization) stakeholders, respectively.

RESULTS

These efforts resulted in the present document containing proposed baseline and endpoint definitions for clinical and morphological outcomes. Although the consensus has inevitably included certain arbitrary consensus choices and compromises, adherence to these proposed standard definitions would provide consistency across future trials, thereby facilitating evaluation of clinical effectiveness and safety of various endovascular revascularization techniques.

CONCLUSIONS

This current document is based on a broad based consensus involving relevant stakeholders from the medical community, industry and regulatory bodies. It is proposed that the consensus document may have value for study design of future clinical trials in endovascular AD therapy as well as for regulatory purposes.

Interest & Impact

Downloads

18 since deposited on 09 Jul 2014
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item